Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
This content is provided by Sharon Gazit
Adv. Gazit, Head of the Corporate and Technology Department, specializes in international-commercial transactions with a dominant technology component, and advises hi-tech and technology companies on their continuous operations and M&A in which they are involved. In addition, Adv. Gazit specializes in corporate financing, commercial agreements, technology agreements, and commercial and technology issues relating to intellectual property.
Adv. Gazit has been recognized as a leading partner in the Israeli private equity and hi-tech field since its early days, and frequently advises companies from their establishment and through their operations as mature and active companies. In addition, she advises VC funds, companies and investors on investments and the realization of holdings. Her many years of experience provide a unique outlook, a deep understanding of the client’s business requirements, and an ability to settle both non-complex and complex transactions.
Adv. Gazit possess significant expertise relating to transactions involving intellectual property licensing, especially in the life sciences fields, and has represented companies in this field for many years. She possesses widespread working relations with the relevant regulatory entities in the field, and advises clients on various matters.
Israel Bar, 1989; Co-Chair, Healthcare and Life Sciences Committee, International Bar Association.
LL.B. Tel Aviv University, 1988